melanoma vaccine (Memorial Sloan-Kettering)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemelanoma vaccine (Memorial Sloan-Kettering)
Drug Alias NameGD3 ganglioside (Memorial Sloan-Kettering)GD3-lactone-KLH vaccine (Memorial Sloan-Kettering)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGanglioside GD3 modulators
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A